Clinical Trial Update: Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs [NA]

View source ↗

Summary

A Nazarbayev University trial in Kazakhstan is evaluating metabolic correction with GLP-1 drugs to improve cardiovascular disease diagnosis and treatment, focus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension
• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonists

Snippet

Sponsor: Nazarbayev University | Conditions: Heart Failure, Diabete Type 2 | NA | Status: ACTIVE_NOT_RECRUITING